Identifying disease modifying genes in multiple sclerosis
- PMID: 11880159
- DOI: 10.1016/s0165-5728(01)00481-7
Identifying disease modifying genes in multiple sclerosis
Abstract
Evidence is mounting that genetic variation influences not only susceptibility to multiple sclerosis (MS), but also its course and severity. Identification of disease modifying genes, however, poses unique challenges, especially on how to classify the course and outcome of the disease in ways that may be relevant to analysis of biological factors that might be influenced by genes. The power of the statistical approaches to detect small effects of individual genes in complex disorders such as MS is problematic, and approaches to estimate power must be appropriate for the data. Nonetheless, using contemporary schemes of classification, genetic variants that influence disease course have been found; in fact, a small number have been confirmed to influence disease course in two or more independent studies. This review addresses strategies relevant to identification of disease modifying genes in MS, and summarizes and critically evaluates the current state of knowledge in this area.
Similar articles
-
Combined effect of HLA-DRB1*1501 and interleukin-1 receptor antagonist gene allele 2 in susceptibility to relapsing/remitting multiple sclerosis.J Neuroimmunol. 1997 Dec;80(1-2):172-8. doi: 10.1016/s0165-5728(97)00153-7. J Neuroimmunol. 1997. PMID: 9413274
-
Association of two variants in IL-1beta and IL-1 receptor antagonist genes with multiple sclerosis.J Neuroimmunol. 2000 Jul 1;106(1-2):220-7. doi: 10.1016/s0165-5728(00)00202-2. J Neuroimmunol. 2000. PMID: 10814801
-
An interleukin 1-receptor-antagonist gene polymorphism is not associated with multiple sclerosis.J Neuroimmunol. 1996 Jul;67(2):143-4. doi: 10.1016/0165-5728(96)00061-6. J Neuroimmunol. 1996. PMID: 8765338 No abstract available.
-
Identification of multiple sclerosis-associated genes.Mayo Clin Proc. 1997 Oct;72(10):965-76. doi: 10.4065/72.10.965. Mayo Clin Proc. 1997. PMID: 9379703 Review.
-
Is multiple sclerosis severity a genetically influenced trait?Neurol Sci. 2000;21(4 Suppl 2):S843-7. doi: 10.1007/s100720070023. Neurol Sci. 2000. PMID: 11205360 Review.
Cited by
-
Genetic correlations of brain lesion distribution in multiple sclerosis: an exploratory study.AJNR Am J Neuroradiol. 2011 Apr;32(4):695-703. doi: 10.3174/ajnr.A2352. Epub 2011 Mar 24. AJNR Am J Neuroradiol. 2011. PMID: 21436341 Free PMC article.
-
Hit-Hit and hit-Run: viruses in the playing field of multiple sclerosis.Curr Neurol Neurosci Rep. 2003 May;3(3):265-71. doi: 10.1007/s11910-003-0087-9. Curr Neurol Neurosci Rep. 2003. PMID: 12760396 Review.
-
IL2RA/CD25 polymorphisms contribute to multiple sclerosis susceptibility.J Neurol. 2007 May;254(5):682-4. doi: 10.1007/s00415-006-0416-4. Epub 2007 Apr 10. J Neurol. 2007. PMID: 17420929 No abstract available.
-
Glatiramer acetate increases IL-1 receptor antagonist but decreases T cell-induced IL-1beta in human monocytes and multiple sclerosis.Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4355-9. doi: 10.1073/pnas.0812183106. Epub 2009 Mar 2. Proc Natl Acad Sci U S A. 2009. PMID: 19255448 Free PMC article.
-
Reproductive history and progressive multiple sclerosis risk in women.Brain Commun. 2020 Nov 17;2(2):fcaa185. doi: 10.1093/braincomms/fcaa185. eCollection 2020. Brain Commun. 2020. PMID: 33409489 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical